Sedi Hadadian, MD
Obstetrics & Gynecology · Burbank, CANPI 1326295452
Payments from drug & device makers
Across 90 payments — averaging $49.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$3K
- AbbVie$381
- Mayne Pharma Commercial LLC$280
- Astellas Pharma US Inc$167
- Organon$151
- Exeltis, USA Inc.$138
- plus $722 from 16 others
What the payments were for
- Consulting fees$2,60059%
- Food & beverage$1,83941%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 8 | $2,600 |
| AbbVie | 29 | $381 |
| Mayne Pharma Commercial LLC | 9 | $280 |
| Astellas Pharma US Inc | 5 | $167 |
| Organon | 3 | $151 |
| Exeltis, USA Inc. | 7 | $138 |
| Hologic Sales And Service, LLC | 5 | $136 |
| Pfizer | 3 | $93 |
| Sage Therapeutics, LLC | 3 | $75 |
| Evofem Biosciences, Inc. | 4 | $74 |
| Johnson & Johnson | 1 | $60 |
| Shield Therapeutics Inc | 1 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Therapeuticsmd, Inc. | 2 | $36 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $20 |
| Smith+Nephew | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Avion Pharmaceuticals | 1 | $18 |
| Cranial Technologies, Inc | 1 | $17 |
| Coopersurgical, Inc. | 1 | $15 |
| Millicent US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOVINE COLLAGEN$400
- NEXTSTELLIS$122
How this compares
$4,439 in reported general payments places this provider in the 85th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 92 | $5,347 |
| CombipatchEstradiol/Norethindrone Acet | 12 | $2,907 |
| Clobetasol Propionate | 13 | $828 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 32 | $759 |
| Estradiol (Twice Weekly)Estradiol | 18 | $590 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Burbank
- Jose MedranoBurbank$173K
- Peyman BanooniBeverly Hills$9.2M
- Vellore BhupathyWhittier$4.3M
- Edwin RamirezOxnard$3.5M
- Nam TranSan Francisco$3M
- Dmitriy RomanenkoSouth Gate$2.7M
- Anita NelsonTorrance$2.1M
- Oleg BessLos Angeles$1.7M
- Rovena ReaganSan Diego$1.7M
- Dana Shippdel Mar$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.